|
⚲
|
| Keyboard |
| Kim Christopher
✚
|
|
|---|---|
| CIK # | 0002040022 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002040022] | |
| 4 | [0002040022] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Apimeds Pharmaceuticals US Inc | |
| Kim Christopher |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apimeds Pharmaceuticals US Inc APUS
Stock Option (right to buy) · derivative
|
2025-10-15 | Grant | 3,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Common Stock, par value $0.01 per share
|
2025-05-16 | Grant | 250,000 | $0.00 | |
|
Apimeds Pharmaceuticals US Inc APUS
Common Stock, par value $0.01 per share
|
2025-05-14 | Buy | 7,730 | $1.86 | 14,378 |
|
Apimeds Pharmaceuticals US Inc APUS
Common Stock, par value $0.01 per share
|
2025-05-13 | Buy | 19,770 | $1.82 | 35,981 |